Diluted EPS came in at $-0.32 (+55.6% YoY), beat the $-0.47 consensus by $0.15.
Trailing eight quarters through Q1 2025
Common questions about Annovis Bio's Q1 2025 earnings report.
Annovis Bio (ANVS) reported Q1 2025 earnings on May 13, 2025 before market open.
Annovis Bio reported diluted EPS of $-0.32 for Q1 2025.
EPS beat the consensus estimate of $-0.47 by $0.15.
Compared to the same quarter a year prior, diluted EPS grew 55.6% from $-0.72.
You can read the 10-Q periodic report (0001558370-25-007584) directly on SEC EDGAR. The filing index links above go to sec.gov.